SEMA3A and neoplasm: To this aim, the authors engineered a mutant version of SEMA3A that cannot interact with NRP1 to prevent vascular permeability, while preserving other desired properties of SEMA3A, such as the repulsion of migrating ECs that promotes blood vessel normalization in vivo and ultimately inhibits tumor growth and dissemination to distant organs [130].